evoke semaglutide trial Two phase 3 trials testing in Alzheimer patients: The trials Novo Nordisk announces topline results

Late-stage trial data released by Pfizer suggest Berobenatide delivers weight loss that is at least comparable to and on some measures better than the current standard-bearers

People who restart after a break must be patient, as it takes time to reach the full dose again

Researchers have investigated BPC-157s potential role in supporting the digestive system and maintaining healthy tissue within the gastrointestinal tract

Akhter Hossain at the University of Melbourne in Australia has suggested rather than adding a fatty acid side chain, a glycan group may work instead which is more hydrophilic and therefore easier to dissolve and purify

Baumeister U, Funke R, Ebnet K, Vorschmitt H, Koch S, Vestweber D (2005) Association of Csk to VE-cadherin and inhibition of cell proliferation